Eli Lilly (LLY) and Pfizer (PFE) are among the major pharmaceutical companies featured in China's commercial insurance innovative drug catalog, the National Healthcare Security Administration said Sunday.
The catalog included 19 drugs for the treatment of cancer, Alzheimer's disease, and other diseases.
Johnson & Johnson (JNJ) and Bristol-Myers Squibb (BMY) also featured on the list.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments